The neurosteroid 3␣-hydroxy-5␣-pregnan-20-one (allopregnanolone) facilitates GABA A receptor-mediated ionic currents via allosteric modulation of the GABA A receptor. Accordingly, allopregnanolone caused an increase in the slow decay time constant of spontaneous GABA-mediated IPSCs in magnocellular neurons recorded in hypothalamic slices. The allopregnanolone effect on IPSCs was inhibited by a G-protein antagonist as well as by blocking protein kinase C and, to a lesser extent, cAMP-dependent protein kinase activities. G-protein and protein kinase C activation in the absence of the neurosteroid had no effect on spontaneous IPSCs but enhanced the effect of subsequent allopregnanolone application. These findings together suggest that the neurosteroid modulation of GABA-mediated IPSCs requires G-protein and protein kinase activation, although not via a separate G-protein-coupled steroid receptor. : hypothalamus; neurosteroid; progestin; allopregnanolone; kinase; phosphorylation; GABA A receptor; G-proteins; whole-cell recording Neuronal function is acutely modulated by a class of steroids, the neurosteroids, that are synthesized de novo in the CNS (Corpechot et al., 1993; Cheney et al., 1995; Schumacher and Baulieu, 1995) . 3␣-Hydroxy-5␣-pregnan-20-one (Allopregnanolone), a progesterone metabolite, has been shown to enhance the GABA A receptor-mediated Cl Ϫ current caused by exogenously applied GABA (Majewska et al., 1986; Harrison et al., 1987; Lambert et al., 1990; Puia et al., 1993; Rupprecht et al., 1993) . The modulatory efficacy of the neurosteroids seems to depend on the subunit composition of the GABA A receptor. Variations in subunit subtypes change or eliminate completely the neurosteroids' ability to modulate GABA currents (Shingai et al., 1991; Zaman et al., 1992; Puia et al., 1993; Zhu et al., 1996; Reynolds, 1998, 1999; Smith et al., 1998; Brussaard et al., 1999) . Receptor phosphorylation seems to play a role in the regulation and modulation of the GABA A receptor complex. Several studies have demonstrated that GABA A receptor function is regulated by phosphorylation via Ca 2ϩ /phospholipid-dependent protein kinase C (PKC) (Krishek et al., 1994; Poisbeau et al., 1999) , cAMP-dependent protein kinase (PKA) (Poisbeau et al., 1999) , Ca 2ϩ /calmodulin-dependent protein kinase II (McDonald and Moss, 1994) , and protein tyrosine kinase (Bureau and Laschet, 1995; Moss et al., 1995; Dunne et al., 1998) and by an unidentified kinase associated with the GABA A receptor (Bureau and Laschet, 1995) . Similarly, there is preliminary evidence that phosphorylation plays a role in the modulation of the GABA A receptor complex by neurosteroids (Gyenes et al., 1994; Leidenheimer and Chapell, 1997) .
Neuronal function is acutely modulated by a class of steroids, the neurosteroids, that are synthesized de novo in the CNS (Corpechot et al., 1993; Cheney et al., 1995; Schumacher and Baulieu, 1995) . 3␣-Hydroxy-5␣-pregnan-20-one (Allopregnanolone), a progesterone metabolite, has been shown to enhance the GABA A receptor-mediated Cl Ϫ current caused by exogenously applied GABA (Majewska et al., 1986; Harrison et al., 1987; Lambert et al., 1990; Puia et al., 1993; Rupprecht et al., 1993) . The modulatory efficacy of the neurosteroids seems to depend on the subunit composition of the GABA A receptor. Variations in subunit subtypes change or eliminate completely the neurosteroids' ability to modulate GABA currents (Shingai et al., 1991; Zaman et al., 1992; Puia et al., 1993; Zhu et al., 1996; Reynolds, 1998, 1999; Smith et al., 1998; Brussaard et al., 1999) . Receptor phosphorylation seems to play a role in the regulation and modulation of the GABA A receptor complex. Several studies have demonstrated that GABA A receptor function is regulated by phosphorylation via Ca 2ϩ /phospholipid-dependent protein kinase C (PKC) (Krishek et al., 1994; Poisbeau et al., 1999) , cAMP-dependent protein kinase (PKA) (Poisbeau et al., 1999) , Ca 2ϩ /calmodulin-dependent protein kinase II (McDonald and Moss, 1994) , and protein tyrosine kinase (Bureau and Laschet, 1995; Moss et al., 1995; Dunne et al., 1998) and by an unidentified kinase associated with the GABA A receptor (Bureau and Laschet, 1995) . Similarly, there is preliminary evidence that phosphorylation plays a role in the modulation of the GABA A receptor complex by neurosteroids (Gyenes et al., 1994; Leidenheimer and Chapell, 1997) .
Neurosteroid levels measured in the CNS and in the blood are correlated with different reproductive endocrine states (Corpechot et al., 1993 (Corpechot et al., , 1997 Heesch and Rogers, 1995; Palumbo et al., 1995; Bixo et al., 1997) . Changes in the hypothalamic allopregnanolone level during the estrus cycle seem to serve a functionspecific modulatory role because they are not accompanied by changes in other brain regions (e.g., cortex) . The oxytocin-and vasopressin-producing magnocellular neurons of the hypothalamic supraoptic nucleus (SON) are sensitive to several neurosteroids (Patchev et al., 1996; Poisbeau et al., 1997; Richardson and Wakerley, 1998) , including allopregnanolone (Purdy et al., 1991; Dayanithi and Tapia-Arancibia, 1996) , which has been shown to potentiate GABA-mediated IPSCs (Brussaard et al., 1997) . During parturition and lactation, the sensitivity of magnocellular neurons to allopregnanolone decreases (Brussaard et al., 1999) , which correlates with underlying changes in the subunit composition of the GABA A receptor complex (Fenelon and Herbison, 1996; Brussaard et al., 1997) .
Although much is known about the modulatory effects of neurosteroids on GABA-mediated currents, very little is known about the underlying molecular mechanisms of neurosteroid modulation of GABA A receptors. We used whole-cell patchclamp recordings in rat hypothalamic slices to study the G-protein and protein kinase dependence of the allopregnanolone effect on spontaneous GABA A receptor-mediated IPSCs in magnocellular neurons of the SON. On the basis of our findings, we propose that phosphorylation of the GABA A receptor is required for the allosteric enhancement of synaptic GABA currents by neurosteroids.
MATERIALS AND METHODS
Slice preparation. Male Sprague Dawley rats (40 -120 gm) were deeply anesthetized with intraperitoneal sodium pentobarbital (50 mg / kg of body weight) and decapitated in a guillotine. The brain was removed rapidly and placed in ice-cold (0 -1°C) artificial C SF (AC SF) bubbled with 100% O 2 . The AC SF contained (in mM): 140 NaC l, 3 KC l, 2.4 CaCl 2 , 1.3 MgSO 4 , 1.4 NaH 2 PO 4 , 11 glucose, and 5 H EPES; pH was adjusted to 7.2-7.4 with NaOH. T wo coronal slices (400 m) containing the SON were sectioned. The slices were hemisectioned, and one hemisection was placed on the ramp of an interface recording chamber immediately after preparation. Heated AC SF (32-34°C) was perf used through the chamber, and 100% O 2 was humidified and directed over the surface of the slice. The remaining hemisections were placed in a storage chamber containing AC SF at room temperature and gently bubbled with 100% O 2 . The hemisection placed on the ramp was allowed to equilibrate in the recording chamber for 1.5-2 hr before the start of experiments. After an experiment involving drugs that do not wash out from the preparation [e.g., tetrodotoxin (TTX) and steroids], the hemisection was removed, and a new section was placed into the chamber and allowed to equilibrate for 30 min before the start of experiments.
Electrodes and solutions. Patch electrodes (resistance, 3-6 M⍀) were pulled from borosilicate glass (1.65 mm outer diameter; 1.2 mm inner diameter; KG-33; Garner Glass) on a Flaming-Brown puller (Sutter Instruments). The pipette solution contained (in mM): 110 D-gluconic acid, 110 C sOH, 10 C sC l, 10 H EPES, 1 NaC l, 1 C aC l 2 , 1 MgC l 2 , 2 Mg-ATP, 0.3 Na-GTP, and 11 EGTA; pH was adjusted to 7.2-7.4 with C sOH. The osmolarity of the solution was ϳ290 mOsm. C s ϩ was included in the solution in the place of K ϩ to block potassium currents. Recordings. Electrodes were placed in the SON under visual control and advanced through the slice in 2 m steps with a piezoelectric microdrive (Nanostepper; Scientific Precision Instruments) set at minimum speed and acceleration settings. A high-resistance seal (Ͼ3 G⍀) was obtained, and the negative pressure was increased to cause the cell membrane to rupture, achieving the whole-cell configuration. Series resistance and whole-cell capacitance were adjusted and continually compensated during the experiment. C ells were identified as magnocellular neurons by the presence of a large transient, voltage-dependent potassium current, or A-current (Bourque, 1988) . C ells were depolarized to 0 mV (i.e., reversal for EPSC s), and their input resistance was calculated from the currents evoked by Ϫ10, Ϫ20, and Ϫ30 mV voltage steps. C ells were monitored in the first 15 min of the recordings for stability, and cells with unstable input resistance or series resistance were discarded. I PSC s were recorded with an Axopatch 1D amplifier (Axon Instruments) and stored on a V HS videocassette.
Data acquisition and anal ysis. All data were low-pass filtered with the amplifier at 2 kHz, digitized at 22 kHz with a Neuro-Corder DR-484 digitizer unit, and stored on videotape for later analysis off-line. Selected data were digitized at 4 -10 kHz and recorded on a personal computer using the Digidata 1200 interface and pCL AM P software on-line (Axon Instruments). Segments of 180 sec of synaptic activity were recorded during the experiment at a holding potential of 0 mV. The obtained traces were analyzed using DATAPAC III software (RUN Technology) to select synaptic events. Raw data were processed by taking the first derivative at each data point using a 7.5 msec moving average. After this transformation, I PSC s were selected by the computer on the basis of a threshold set manually. The selected events were confirmed by eye, and detection errors were corrected manually. Event amplitudes and instantaneous event frequencies calculated by the program were exported and f urther analyzed in a spreadsheet (E xcel; Microsoft Corporation). I PSC s were aligned by their peak amplitude and averaged, and average I PSC traces were analyzed using C lampfit (Axon Instruments). The decay phase of the average I PSC was fitted by a double exponential. Statistical analyses of the data were performed with the Wilcoxon signed rank test or Kruskal -Wallis ANOVA (depending on whether two or more experimental groups, respectively, were compared) for comparing the effects on the mean using SigmaStat (Jandel Scientific, Corte Madera, CA) and SPSS for Windows (SPSS Inc., Chicago, IL). Mean amplitude, frequency, and decay time constant values of I PSC s from individual cells were compared from control, wash-in, and washout periods using ANOVA for repeated measures. Changes in the decay time constant of I PSC s are expressed as the mean Ϯ SE of percent changes across cell groups. Probability values Ͻ0.05 were considered significant.
Pharmacolog y. The steroids allopregnanolone and 3␤-hydroxy-5␣-pregnan-20-one (isopregnanolone) were dissolved in 99.7% ethanol to produce a stock solution (10 g/l) after arrival in the laboratory and were stored at Ϫ20°C. On use, the steroid stock solution was dissolved in AC SF, giving an ethanol concentration Ͻ0.03% for final drug concentrations of 1 M. This concentration of ethanol does not affect spontaneous GABA A receptor-mediated I PSC s, as determined in a series of control experiments (n ϭ 6). Steroids were bath applied at a final concentration of 1 M. In experiments to test the effect of the intracellular application of allopregnanolone, the steroid from the stock solution was added to the patch solution (1 M final steroid concentration), aliquotted, and stored at Ϫ20°C. The protein kinase blockers H-89 (1 M), Rp-8-bromo-guanosine 3Ј,5Ј-cyclic monophosphorothioate (8-BrcGM PS; 5 and 40 M), and bisindolylmaleimide (GF109203X; 500 nM) were dissolved in sterile water and stored at Ϫ20°C. On use, these chemicals were dissolved in AC SF and applied to the bath 15 min before the neurosteroid, and the application was continued during neurosteroid administration. For experiments in which G-protein f unction was blocked, GDP-␤-S (500 M) was added, and GTP alone or GTP and ATP were omitted from the patch solution. For experiments in which G-protein or protein kinase C activity was stimulated, GTP-␥-S (100 M) or phorbol-12-myristate-13-acetate (PM A; 40 nM) was dissolved in the patch solution, aliquotted, and stored at Ϫ20°C until use.
RESULTS
Within 1-2 min of establishing the whole-cell configuration, recorded neurons were identified as SON magnocellular neurons by the presence of a transient, voltage-dependent K ϩ current, I A (Bourque, 1988) . The recorded cells were then depolarized to 0 mV to isolate IPSCs. Spontaneous outward synaptic currents were identified as GABA-mediated IPSCs by blocking them with the bath application of the GABA A receptor antagonist bicuculline methiodide (10 M; n ϭ 5). A total of 85 cells were used in this study after an initial 15 min baseline recording period was established during which no run-down of IPSCs occurred and no change in the series resistance of the recording or in the input resistance of the cell was detected. Spontaneous IPSCs recorded in control conditions had an amplitude of 15-500 pA, a frequency of 0.2-7.0 Hz, and a decay that was best fitted in individual IPSCs with a single-exponential function.
Allopregnanolone effect on GABA A receptor-mediated IPSCs
The effect of allopregnanolone (1 M) was investigated using a 15 min bath application of the steroid. IPSCs were collected over a 3 min period before and after 15 min of steroid application, and an ensemble average was calculated from each recording period, as shown in Figure 1 . The decay phase of the averaged IPSCs was best fitted by a double-exponential function with a fast ( 1 ) and a slow decay time constant ( 2 ). The mean value for 1 was 6.2 Ϯ 0.3 msec, whereas the mean value for 2 was 27.7 Ϯ 1.6 msec (n ϭ 21). The relative contribution of 2 to the peak amplitude of the IPSC was 38.2 Ϯ 5.2%. Allopregnanolone increased 1 to 7.1 Ϯ 0.2 msec (21.4 Ϯ 8.0% on average; p Ͻ 0.05, paired Student's t test; n ϭ 21) and 2 to 44.2 Ϯ 3.1 msec (67.2 Ϯ 14.8% on average; p Ͻ 0.001, paired Student's t test; n ϭ 21). This represented a 15.7 Ϯ 2.7% increase in the relative contribution of 2 to the peak IPSC amplitude. Because the magnitude of the increase in 2 was considerably larger than that in 1 , we focused our analysis on the slow decay time constant of the IPSC to study the effects of the neurosteroid.
After the start of the bath application of allopregnanolone, ϳ7-11 min was required to detect the first IPSCs that showed a substantially longer decay, and the number of affected IPSCs increased with the time of the drug application. The effect continued to augment even after the termination of the steroid application, stabilizing 30 -45 min after the initial exposure to the steroid. In experiments in which cells were recorded for longer durations, we found that the fast and the slow components of the average IPSC decay increased further 20 -30 min after terminating the allopregnanolone application. The fast component increased to 8.3 Ϯ 0.7 msec (36.2 Ϯ 10.5% mean percent change), and the slow component increased to 58.0 Ϯ 6.4 msec (122.3 Ϯ 25.8% mean percent change; n ϭ 14) (Fig. 1 A,B) . The effect of allopregnanolone was reversible but long lasting, requiring washout periods of Ͼ60 min (n ϭ 4).
No significant changes in the amplitude (64.8 Ϯ 7.0 to 61.5 Ϯ 4.6 pA; 1.8 Ϯ 6.2% mean percent change) or the frequency (1.9 Ϯ 0.3 to 1.3 Ϯ 0.2 Hz; Ϫ17.5 Ϯ 7.9% mean percent change) of averaged IPSCs were seen with allopregnanolone application when the recorded cells were analyzed as a group (Fig. 1 B) . However, some cells did show changes in IPSC frequency and amplitude that were significant in within-cell comparisons, although these changes were not consistent throughout the population of recorded cells (Fig. 1C) . The experiments were repeated in TTX (1.5 M) to determine whether the trend toward a decrease in IPSC frequency was caused by a presynaptic, spikemediated action of allopregnanolone. Whereas the allopregnanolone effect on the IPSC decay was retained in TTX, the effect on the IPSC frequency was completely blocked (2.2 Ϯ 0.6 vs 1.9 Ϯ 0.3 Hz in control; Ϫ0.2 Ϯ 7.3% mean percent change; n ϭ 8), suggesting a presynaptic inhibitory action of the allopregnanolone that reduced the IPSC frequency in some cells.
The specificity of the steroid effect was determined in control experiments using isopregnanolone, a physiologically inactive stereoisomer of allopregnanolone. The effect of isopregnanolone was tested at 1 M (n ϭ 5) and 10 M (n ϭ 4) concentrations to ensure that steroid application did not cause changes in the membrane structure that led to a nonspecific modulation of the synaptic currents. Isopregnanolone did not change significantly the IPSC decay phase (at 1 M, 2 , 33.0 Ϯ 2.5 vs 31.4 Ϯ 2.8 msec in controls; mean percent change ϭ ϩ6.6 Ϯ 6.7%; at 10 M, 2 , 35.9 Ϯ 5.2 vs 33.2 Ϯ 2.6 msec in controls; mean percent change ϭ 12.9 Ϯ 14.9%) (Fig. 2 A,C) , amplitude (at 1 M, 78.6 Ϯ 15.9 vs 77.5 Ϯ 17.2 pA; mean percent change ϭ Ϫ4.3 Ϯ 5.9%; at 10 M, 53.4 Ϯ 5.0 vs 71.7 Ϯ 15.0 pA in controls; mean percent change ϭ Ϫ21.0 Ϯ 7.4%), or frequency (at 1 M, 1.0 Ϯ 0.2 vs 1.2 Ϯ 0.3 Hz in controls; mean percent change ϭ 2.3 Ϯ 12.0%; at 10 M, 1.6 Ϯ 0.3 vs 2.4 Ϯ 1.4 Hz in controls; mean percent change ϭ 6.1 Ϯ 23.9%).
To ensure that the increase in the IPSC decay time constant caused by allopregnanolone was not attributable to a change in the passive electrical properties of the recorded cells, we also investigated allopregnanolone's effect on the frequency, amplitude, and decay of the EPSCs recorded at a holding potential of Ϫ70 mV. We found no changes in any of the properties of the EPSCs (data not shown).
To confirm that allopregnanolone's actions were mediated by binding to an extracellular site, we applied allopregnanolone (1 M) directly into the cell cytosolic compartment by including it in the patch solution. It is estimated that the electrode solution equilibrates completely with the cell's internal solution within ϳ3 min of achieving the whole-cell configuration (Marty and Neher, 1983) . IPSCs were recorded immediately after rupturing the cell membrane to obtain control values and then again after 15 min of recording. Allopregnanolone applied intracellularly had no significant effect on the decay phase ( 2, 29.9 Ϯ 3.9 vs 28.0 Ϯ 2.8 msec in controls; mean percent change ϭ 5.8 Ϯ 8.1%; n ϭ 8), amplitude (56.8 Ϯ 8.1 vs 55.7 Ϯ 7.1 pA in controls; mean percent change ϭ Ϫ2.8 Ϯ 6.8%), or frequency (0.7 Ϯ 0.1 vs 0.8 Ϯ 0.2 Hz in controls; mean percent change ϭ 4.3 Ϯ 13.1%) of the IPSCs (Fig. 2 B,C) , indicating that the steroid does not bind to an intracellular receptor to modulate the GABA currents.
G-protein dependence of the allopregnanolone effect
We tested whether G-proteins play a role in the modulation by allopregnanolone of GABA IPSCs by blocking G-protein activity. A G-protein antagonist, the nonhydrolyzable GDP analog GDP-␤-S (500 M), was included in the patch solution, and GTP (n ϭ 6) or both GTP and ATP (n ϭ 4) were omitted from the patch solution. The GDP-␤-S solution was allowed to diffuse into the cells for 15 min before the start of the allopregnanolone (1 M) application in the bath. Whereas the GDP-␤-S solution had no effect on the frequency or amplitude of IPSCs, it completely blocked the effect of allopregnanolone on the IPSC decay phase (GTP omitted, 51.2 Ϯ 10.2 vs 47.3 Ϯ 7.94 msec in controls; mean percent change ϭ 6.2 Ϯ 14.1%; n ϭ 6; NS; GTP and ATP omitted, 45.9 Ϯ 6.5 vs 44.4 Ϯ 5.5 msec in controls; mean percent change ϭ 4.3 Ϯ 8.5%; n ϭ 4; NS) (Fig. 3) .
Protein kinase dependence of the allopregnanolone effect
The G-protein dependence of the modulation of GABA IPSCs by allopregnanolone suggests that the steroid's actions may be mediated by protein phosphorylation. To determine whether phosphorylation is required for the expression of the allopregnanolone effect, protein kinase inhibitors selective for PKC, PKA, and the cGMP-dependent protein kinase (PKG) were tested.
Treatment of the slices with the specific PKC antagonist bisindolylmaleimide (500 nM) completely abolished the effect of allopregnanolone on the IPSC slow decay (41.9 Ϯ 4.0 vs 36.7 Ϯ 2.4 msec in controls; mean percent change ϭ 2.5 Ϯ 3.2%; n ϭ 5) (Fig.  4 B) . Treatment of the slices with the PKA antagonist H-89 (1 M) resulted in a nonsignificant change in the IPSC decay in response to allopregnanolone (55.6 Ϯ 13.3 vs 37.4 Ϯ 4.3 msec in controls; mean percent change ϭ 28.0 Ϯ 18.9%; n ϭ 5; NS) (Fig.  4C) . Treatment with the PKG inhibitor Rp-8-Br-cGMPS (5 and 40 M) did not attenuate the allopregnanolone effect on the slow decay time constant of IPSCs (at 5 M, 74.5 Ϯ 18.0 vs 42.8 Ϯ 2.3 msec in controls; mean percent change ϭ 73.9 Ϯ 32.9%; n ϭ 5; at 40 M, 68.1 Ϯ 6.8 vs 32.3 Ϯ 3.1 msec in controls; mean percent change ϭ 80.1 Ϯ 20.1%; n ϭ 5) (Fig. 4 D) . Blockade of allopregnanolone's actions by the PKC inhibitor was significant ( p Ͻ 0.05), whereas the effect of the PKA and PKG blockers was nonsignificant (Kruskal-Wallis ANOVA on ranks) (Fig. 4 E) . . G-Protein dependence of the allopregnanolone effect. The G-protein dependence of the allopregnanolone effect on the IPSC slow decay was tested by inhibiting G-protein activity with GDP-␤-S (500 M) and 0 mM ATP and/or GTP applied intracellularly. Averages of IPSCs over 3 min were normalized and superimposed. A, The slow component of the average IPSC decay increased after a 15 min application of allopregnanolone (ALLO) by an average of 51.2% in a control cell. B, Allopregnanolone had no effect after intracellular application of the GDP-␤-S solution (GDP-␤-S & ALLO). C, The average change in the slow IPSC decay was 67.3 Ϯ 14.8% in control cells and 2.4 Ϯ 6.5% in cells perfused with GDP-␤-S (n ϭ 7; *p Ͻ 0.01, Wilcoxon rank sum test). reg., Regular.
Steroid activation of a G-protein-and protein kinase-coupled receptor
The G-protein and protein kinase dependence of the allopregnanolone effect on IPSCs suggested that the steroid may be acting at a separate, G-protein-coupled receptor. We tested this hypothesis by stimulating G-protein and PKC activity in an attempt to mimic the effect of allopregnanolone. Inclusion of the G-protein agonist GTP-␥-S (100 M) in the pipette solution did not alter the decay of GABA IPSCs (Fig. 5B) . However when the intracellular application of GTP-␥-S was followed by the bath application of allopregnanolone (1 M), the steroid's effect on the decay time constant of IPSCs was not significantly different from the effect of allopregnanolone without intracellular GTP-␥-S ( 2 with GTP-␥-S, 61.2 Ϯ 4.2 vs 34.5 Ϯ 5.1 msec in controls; mean percent . The PKC antagonist completely abolished the effect of allopregnanolone ( B), the PKA antagonist partially blocked the effect ( C), and the PKG antagonist appeared to have no effect on the allopregnanolone-induced increase in IPSC decay ( D) . E, The average change in the slow decay of IPSCs caused by allopregnanolone in the absence and presence of protein kinase antagonists is shown. The effect of allopregnanolone (ALLO; control % change, ϩ67.3 Ϯ 14.8%) was significantly inhibited by the PKC blocker (% change, ϩ6.8 Ϯ 5.3%; n ϭ 5; *p Ͻ 0.05) but not by the PK A blocker (% change, ϩ28.0 Ϯ 18.9%; n ϭ 5) and was not changed by the PKG blocker (% change, ϩ80.1 Ϯ 20.1%; n ϭ 5) (Kruskal-Wallis one-way ANOVA on ranks; post hoc Dunn's test). change ϭ ϩ85.2 Ϯ 21.3%; n ϭ 4; 2 without GTP-␥-S, 44.2 Ϯ 3.1 vs 27.7 Ϯ 1.6 msec in controls; mean percent change ϭ ϩ67.3 Ϯ 14.8%).
The PKC activator PMA (40 nM) was applied intracellularly through the recording pipette in five cells (Fig. 5C) . PMA had no effect on the decay time constant of the IPSCs (37.9 Ϯ 1.2 vs 36.0 Ϯ 3.3 msec in controls; mean percent change ϭ ϩ6.3 Ϯ 6.7%; n ϭ 5). The effect of allopregnanolone on the IPSC decay after PMA application was not significantly different (80.4 Ϯ 18.4 vs 36.0 Ϯ 3.3 msec in controls; mean percent change ϭ ϩ129.6 Ϯ 62.0%) in these cells compared with the allopregnanolone effect in the absence of PMA (44.2 Ϯ 3.1 vs 27.7 Ϯ 1.6 msec in controls; mean percent change ϭ ϩ67.3 Ϯ 14.8%) (Fig. 5C) . Thus, in magnocellular neurons of the supraoptic nucleus, the actions of allopregnanolone seem not to be mediated by the activation of a separate G-protein-and protein kinase-coupled receptor, because the steroid effect is not mimicked by exogenous activation of G-proteins or PKC.
DISCUSSION
In our experiments on hypothalamic magnocellular neurons, the neurosteroid allopregnanolone caused an increase in the time constant of decay of spontaneous, GABA-mediated IPSCs. No consistent effect of the neurosteroid on either the amplitude or the frequency of the IPSCs was observed. A trend toward a neurosteroid-induced decrease in the frequency of spontaneous IPSCs was abolished by TTX, suggesting that allopregnanolone may also enhance inhibition in local presynaptic GABA neurons. These findings corroborate those of Brussaard et al. (1997) , who also found a neurosteroid effect on the decay phase, but not on the amplitude or frequency, of spontaneous IPSCs recorded in the same cells. Zhang and Jackson (1994) found similar effects of allopregnanolone and of a related steroid, alphaxalone, on GABA currents recorded in the magnocellular nerve terminals in the neurohypophysis. Thus, the main effect of the neurosteroid on magnocellular neurons appears to be to change the decay kinetics of synaptic GABA currents, without altering the probability of GABA release or the postsynaptic sensitivity to GABA. Different actions of neuroactive steroids on synaptic GABA signals have been reported in various other cell preparations, including the neurointermediate lobe of the pituitary. Using hypothalamicpituitary cocultures, Poisbeau et al. (1997) reported an allopregnanolone-induced increase in the frequency and amplitude, but no effect on the decay, of spontaneous IPSCs recorded in neurointermediate pituitary cells. IPSCs recorded in spinal neurons of Xenopus laevis underwent an increase in the frequency as well as the decay in response to a related steroid, 5␤-pregnan-3␣-ol-20-one (Reith and Sillar, 1997) . These results suggest that the effects of neurosteroids on GABAergic synaptic transmission are highly dependent on the subunit composition of the GABA A receptors and on the specific neural environment, which show considerable diversity in different brain regions (Zhang et al., 1991; Criswell et al., 1993; Benke et al., 1994; Inglefield et al., 1994; Dunn et al., 1996; Huntsman et al., 1996; Mize and Butler, 1997) .
The effect of allopregnanolone in our preparation, as in others (Peters et al., 1988; Le Foll et al., 1997; Calogero et al., 1998) , was stereospecific and not a consequence of a nonspecific steroid action on the cell membrane, because the physiologically inactive allopregnanolone isomer isopregnanolone did not show any effect on the GABA currents. Although the precise location of the allopregnanolone binding site on the GABA A receptor is not known, it is presumed that the steroid binds to a portion of the receptor that is buried in the lipophilic phospholipid bilayer (Baulieu, 1998; Rick et al., 1998) . On the basis of our results and those of others (Lambert et al., 1990) , this binding site appears to be accessible only from the outside of the cell, because intracellular application of the steroid had no effect.
The initial effect of the steroid occurred slowly, after 7-11 min, and increased in magnitude with time during the allopregnanolone application and for 15-30 min into washout of the steroid. This suggests that considerable time was required to reach a physiologically effective concentration of the steroid in the slice preparation. The slow onset together with the slow reversal (Ͼ60 min) of the allopregnanolone effect was probably caused by the steroid's lipophilic nature, which would account for the slow equilibration of the steroid concentration in the slice with wash-in and its slow clearing with washout.
Blockade of G-protein function and PKC activity abolished the allopregnanolone-mediated slowing of the IPSC decay, suggesting that the steroid may act via a separate G-protein-coupled receptor. However, exogenous activation of G-proteins or PKC in the absence of allopregnanolone failed to mimic the effect of the neurosteroid on IPSCs, indicating that the steroid did not activate a separate G-protein-and protein kinase-signaling pathway. Thus, it seems that direct binding of the neurosteroid to the GABA A receptor is required for modulation of the GABA IPSCs, but its binding and/or effectiveness is G-protein and protein kinase dependent. This suggests a mechanism by which neurosteroid binding and kinase-mediated phosphorylation must be coincident to alter GABA currents. In Figure 6 , we provide two possible models that account for these observations. In the first case, the GABA A receptor must be in a phosphorylated state for the steroid to bind to the receptor, and blocking phosphorylation (i.e., favoring dephosphorylation) prevents the steroid from binding (Fig. 6 A) . In the second case, binding of the steroid causes a conformational change in the GABA A receptor that exposes phosphorylation sites in the protein that were previously inaccessible to protein kinase (Fig. 6B) . Phosphorylation of the GABA A receptor is then catalyzed by constitutive kinase activity. The proposed models account for the allosteric modulation of the GABA A receptor by the neurosteroid (Majewska, 1990; Hawkinson et al., 1994; Lambert et al., 1995; Maitra and Reynolds, 1998) , as well as the requirement for phosphorylation of the receptor by continuous kinase activity. Other molecular mechanisms could also explain these findings, including phosphorylation of other proteins associated with the GABA A receptor, such as gephyrin (Giustetto et al., 1998) , rapsyn (Yang et al., 1997) , and GABA A receptor-associated protein (Wang et al., 1999) , as well as the inhibition of phosphatase activity.
Neurosteroid efficacy in modulating GABA A receptormediated currents is mainly influenced by the ␣ and ␥ subunit subtypes of the GABA A receptor (Shingai et al., 1991; Zaman et al., 1992; Reynolds, 1998, 1999) . The GABA A receptors in magnocellular neurons are comprised of ␣1, ␣2, ␤2/3, and ␥2 subunits Herbison, 1995, 1996; . The expression of ␣1 and ␣2 subunits changes in magnocellular neurons during parturition and lactation, resulting in the ␣1-to-␣2 ratio increasing from 1/1 to 1/4 (Brussaard et al., 1997 (Brussaard et al., , 1999 . This change in ␣ subunit expression parallels a change in the decay time constant of spontaneous IPSCs and in the neurosteroid sensitivity of the GABA A receptor (Brussaard et al., 1999) . Changes in ␥2 subunit expression have also been reported in magnocellular neurons during lactation, although these changes appear to be specific to vasopressin-secreting neurons of the paraventricular nucleus (Fenelon and Herbison, 1996) . Thus, changes in the neurosteroid sensitivity of the GABA A receptor may be a result of differential receptor subtype expression under different physiological conditions, which may influence the phosphorylation state of the receptor.
The ␣1 and ␣2 subunits of the receptor, although playing a major role in determining the GABA A receptor's sensitivity to allopregnanolone, have not been shown to be phosphorylated by PKC (Kellenberger et al., 1992; Moss et al., 1992) . However, the ␥2 subunit is phosphorylated by PKC on the Ser327 and Ser343 residues (Krishek et al., 1994) . Thus, the importance of the ␥2 subunit for the neurosteroid modulation of GABA currents together with our finding of a phosphorylation dependence of the neurosteroid effect on IPSCs suggests that the neurosteroidmediated phosphorylation of the GABA A receptor may be occurring at the ␥2 subunit. (Kellenberger et al., 1992; Moss et al., 1992; Lin et al., 1996) .
Outside-out patch recordings have revealed that allopregnanolone modulates both the open time and opening frequency of the GABA A receptor channel (Lambert et al., 1990; Puia et al., 1990; Twyman and Macdonald, 1992) . The fact that allopregnanolone modulation is sustainable in the outside-out patch configuration, in which GABA receptors are isolated in an excised patch of membrane, suggests either that receptor phosphorylation is maintained after excision or that the G-protein and protein kinase machinery is closely associated with the GABA A receptor. The close association of an unknown protein kinase with the GABA A receptor complex has been demonstrated using purified receptor preparations (Sweetnam et al., 1988; Bureau and Laschet, 1995) .
The slow decay phase of biexponentially decaying GABA currents has been attributed to the desensitization and reopening of the GABA A receptor channels (Jones and Westbrook, 1995) . The neurosteroid 3␣,21dihydroxy-5␣-pregnan-20-one (THDOC) has been shown to prolong the slow deactivation of GABA-mediated currents by slowing the recovery of GABA A receptors from the desensitized state (Zhu and Vicini, 1997) . We found that allopregnanolone slowed both the fast decay phase and the slow decay phase of synaptic IPSCs, although the effect on the slow deactivation of the IPSCs was considerably more pronounced. This suggests that, like THDOC, allopregnanolone may also be affecting the time course of recovery of GABA A receptors from desensitization. Enhancing or maintaining phosphorylation of the GABA A receptors in hippocampal neurons by blocking phosphatase activity has been shown to increase the decay kinetics of IPSCs (Jones and Westbrook, 1997) . Our findings indicate that phosphorylation of GABA A receptors in hypothalamic neurons is necessary for allopregnanolone to cause a decrease in the decay kinetics of synaptic IPSCs. This suggests either that the ongoing phosphorylation necessary for the neurosteroid's effect targets sites on the GABA A receptor different from those of the phosphorylation caused by blocking phosphatase activity or that there are differences in the effects of phosphorylation on GABA A receptors in hippocampal and hypothalamic neurons.
Our finding that GABA A receptor modulation by allopregnanolone is G-protein and protein kinase dependent, although it may be unique to GABA A receptors expressing the subunit composition found in hypothalamic magnocellular neurons, indicates a new level of complexity in the regulation of GABA A receptor physiology by neurosteroids. Figure 6 . Models of G-protein and protein kinase dependence of GABA A receptor modulation by allopregnanolone. Our findings suggest that phosphorylation of GABA A receptors is necessary for the neurosteroid regulation of synaptic GABA currents, although enhancing G-protein and PKC activity alone is not sufficient to mimic the effect of the neurosteroid. This codependence on receptor phosphorylation and steroid presence can be explained by the following two models. A, Top, The first model is one in which the GABA A receptor is constitutively phosphorylated ( P), allowing the neurosteroid (ALLO; A) to bind and increase channel opening and chloride flux. Bottom, Blocking G-protein and/or PKC activity leads to dephosphorylation of the channel, causing a conformational change in the receptor protein that prevents the neurosteroid from binding. B, Top, In the second model, in the absence of the neurosteroid the phosphorylation site (Ser/Thr) in the GABA A receptor is hidden from the constitutively active PKC. Bottom, After allopregnanolone binding, a conformational change in the GABA A receptor occurs, and the Ser/Thr residue(s) (open diamond) becomes exposed for phosphorylation by PKC, increasing channel opening and chloride influx. PLC, Phospholipase C.
